The week at Retraction Watch featured a mysterious retraction from PLOS ONE, and a thoughtful piece by a scientist we’ve covered frequently on where we went wrong in that coverage. Here’s what was happening elsewhere: “Is Economics Research Replicable? Sixty Published Papers from Thirteen Journals Say ‘Usually Not.’” FDA commissioner Robert Califf took his name … Continue reading Weekend reads: FDA nominee authorship questions; low economics replication rates